HealthEconomics.Com

Connected. Community.

  • facebook
  • linkedin
  • twitter
  • vimeo
  • rss
  • Will Improving Adherence Optimize Medication Use?
  • News
  • Jobs
    • HE Jobs Portal
    • View all Jobs
    • Post a Job
  • Value, Evidence and Access Marketplace
    • Visite the Marketplace
    • On-demand Webinar
  • Industry Events
    • HealthEconomics.Com Webinars
    • View Conferences
    • View Webinars
  • Newsletters
    • Subscribe
    • View All
  • Blog
  • Resources
    • Value Communication
    • Free Marketing Consultation!
    • The Future of Print Medical Journals: How to Stay Relevant
    • Be a Better Writer
    • White Papers
    • Education Resources
    • Syndicated Reports
    • Books
    • Databases
    • Blogs
      • HE-Artists
      • Podcasts
  • HE Institute
You are here: Home / Archives for Featured

Transforming the COVID-19 Pandemic Into a Business

Thanks to widespread efforts to develop tools against COVID-19, several effective vaccines now exist. Still, data remain unclear regarding the frequency of possible booster shots and if current vaccines will require modifications in order to be effective against COVID-19 variants. The prices of […]

more info 02/12/2021View Related Articles
Bookmark and Share

How Can Biden Lower Drug Costs Without Impacting Innovation?

A recent article explores why drug prices are so high in the United States and delves into solutions that would reduce prices without affecting the rapid pace of progress. Independent review boards could be the answer. Although ICER (Institute for Clinical and Economic Review) releases reviews with […]

more info 02/12/2021View Related Articles
Bookmark and Share

Designing Clinical Trials During COVID-19 ERA

The ongoing pandemic has led to chaos in many industries, including in clinical trial design. The use of RWE (real world evidence) might be one solution for upended trials and incomplete data. A recent article details these challenges and how RWE can be used to make important decisions in the […]

more info 02/11/2021View Related Articles
Bookmark and Share

How Should COVID-19 Vaccines Be Priced?

The US government has entered into contracts with several pharmaceutical companies to deliver COVID-19 vaccines. Although it is currently not clear how long immunity from these vaccines will last and if booster shots will be needed, vaccination efforts have provided much-needed hope. However, […]

more info 02/11/2021View Related Articles
Bookmark and Share

[Whitepaper] Understanding and Using SDOH Data

SDOH (social determinants of health) data can be incredibly valuable. While these data can be immensely useful in reducing medical costs and in improving outcomes, it can be difficult to actually use these data. A new whitepaper provides insight on understanding and processing SDOH data. “Based […]

more info 02/11/2021View Related Articles
Bookmark and Share

The Battle for FDA Commissioner

Advocacy groups are concerned that Acting Commissioner Janet Woodcock will become FDA Commissioner under the Biden administration, stating that she has contributed to the opioid epidemic. She also overruled a recommendation against dubious Duchenne Muscular Dystrophy drug eteplirsen, a decision that […]

more info 02/11/2021View Related Articles
Bookmark and Share

Pros and Cons of Newsom’s Vaccine Distributer Pick

California Governor Newsom picked Blue Shield of California to distribute COVID-19 vaccines in an emergency authorization process. The role of Blue Shield is to serve as a centralized distributor for the state, rather than the alternative approach of each county being responsible for its own vaccine […]

more info 02/11/2021View Related Articles
Bookmark and Share

Matthew McHugh Appointed Director for Health Outcomes and Policy Research

Matthew McHugh is taking on a new role as Director for Health Outcomes and Policy Research (CHOPR) at the University of Pennsylvania School of Nursing. This highly regarded evidence-based program makes decisions based on patient care and outcomes. McHugh’s previous roles were as Independence Chair […]

more info 02/10/2021View Related Articles
Bookmark and Share

Remdesivir Effective and Profitable for Gilead – And Controversial

Antiviral remdesivir had been developed before the onset of the global COVID-19 pandemic, but was rather unsuccessful as a treatment for either Ebola or hepatitis C. Early on in the pandemic, remdesivir faced substantial controversy regarding its effectiveness. Now, it’s widely regarded as a tool to […]

more info 02/10/2021View Related Articles
Bookmark and Share

Cytel Whitepaper Notes Changes in Clinical Trial Design

Advances in computation tools have forever changed clinical trial design and analysis. According to Nobel Prize winning behavioral economists Daniel Kahnemann and Amos Tversky, “statistical intuitions” can be affected by a variety of external factors. Understanding and making these statistical […]

more info 02/10/2021View Related Articles
Bookmark and Share

Why Are US Drugs 344% More Expensive?

A recent study from the RAND Corporation comparing generic and brand-name drug prices in the US to those in other OECD countries found shocking results. While generic drug prices in the US are lower than in a number of other countries, brand name drugs were 344% more expensive. “As debate […]

more info 02/10/2021View Related Articles
Bookmark and Share

New Scientist.com President Committed to Booming Future

Daniel Kagan is now President of Scientist.com. He was previously Vice President of Research and Chief Operating Officer, roles in which he succeeded in substantially growing the company—from $11M in sales in 2015 to $265M USD in 2020. Now, he plans to launch BaaS (Biotech-as-a-service), a service […]

more info 02/10/2021View Related Articles
Bookmark and Share

Tenacious Sheila McLean Joins Patients for Affordable Drugs

Sheila Mclean began her position as Executive Director of Patients for Affordable Drugs in January 2021. In her new role, Sheila will draw on her vast experience as a journalist, Mid-Atlantic President of Markstein, and North America Social Purpose & Sustainability Practice Director of MSL […]

more info 02/09/2021View Related Articles
Bookmark and Share

A Conversation with Perry Cohen on COVID-19 and PBMs

A recent episode of Tuning In to the C-Suite's Meet the Board features Perry Cohen. As CEO of The Pharmacy Group, Perry provides insight into the role of pharmacy benefit managers (PBMs) and the global COVID-19 response. “Perry has been on MHE's Editorial Advisory Board for over 25 years and has […]

more info 02/09/2021View Related Articles
Bookmark and Share

PhRMA Details Concerns Over Recent HHS Ruling

The Department of Health and Human Services (HHS) released a mid-January ruling relating to insurance enrollment, changes to the Premium Adjustment Percentage calculation, and manufacturer cost-sharing assistance programs. In recent years, these programs have been immensely useful in effective […]

more info 02/09/2021View Related Articles
Bookmark and Share

Science Invites Insight on 20th Anniversary of Human Genome Sequencing Project

Leading journal Science invited researchers to share insight into data integrity, polygenic disease risk, ethics related to genomics, the downfalls of insufficient diversity, and affordability in precision medicine, among other topics. Despite considerable progress into understanding disease and […]

more info 02/09/2021View Related Articles
Bookmark and Share

ISPOR Short Course Begins February 10th – Network Meta-Analysis in Relative Effectiveness Research

Sarah Goring and Jeroen Jansen will present a short course on February 10th and 11th for two hours per day. Some experience with statistics and meta-analysis is necessary. “Based in part on the ISPOR Task Force Reports on Indirect Treatment Comparisons, the fundamentals and concepts of network […]

more info 02/09/2021View Related Articles
Bookmark and Share

URAC Partners with Acentrus Specialty to Improve Patient Care

Healthcare accreditation organization URAC and pharmacy network Acentrus Specialty have partnered to improve patient outcomes and access to care. According to URAC, this move will allow the organization to accredit more healthcare systems and pharmacies. Specialty Vice President George Zula […]

more info 02/08/2021View Related Articles
Bookmark and Share

Using RWD to Target Care Disparities in Cancer

Despite attempts to reduce or eliminate disparities in healthcare, these gaps continue to exist. When it comes to cancer, socioeconomic disparities increased even while the overall death rate decreased substantially. The ERACE (Engaging Research to Achieve Cancer Care Equality) initiative seeks to […]

more info 02/08/2021View Related Articles
Bookmark and Share

Governor Baker Estimates $70 Million in Overcharging Penalties

A 2022 budget proposal released by Governor Charlie Baker estimates that $70 million will be collected from pharmaceutical companies for overcharging. The majority of the funds will go to a trust fund for community health centers and hospitals. Skeptics suggest that proposing penalties during the […]

more info 02/08/2021View Related Articles
Bookmark and Share

Global HTA Comparison Finds 3 Top Organizations–Including ICER

Eight global HTA (health technology assessment) organizations were compared in a recent study. The leaders were NICE (UK), ICER (US), and TLV (Sweden). Only these three institutions “were closest to achieving the dual aim of improved sustainability and patient centricity.” In response to feedback […]

more info 02/08/2021View Related Articles
Bookmark and Share

ICER Evidence Report for Inclisiran Released

Inclisiran by Novartis may be priced lower than other drugs targeting LDL cholesterol. Now that ICER has released its pricing report, the next question is: what will Novartis do?  that keeping inclisiran cost-effective is a serious consideration. “In our recent Evidence Report, ICER concluded […]

more info 02/08/2021View Related Articles
Bookmark and Share

Creating Master Protocols for Clinical Trials with Bayesian Methods

Clinical researchers have sought to streamline protocols and to thereby improve both reproducibility and efficiency. As a result, the use of master protocols in the drug development field has become more widespread. Analysis of the resulting data also requires a “master method.” In this webinar, […]

more info 02/05/2021View Related Articles
Bookmark and Share

Local Officials Join in Fight Against High Drug Prices

High drug costs in the US result from a number of factors and face criticism from many different parties. Recently, local officials in one Pennsylvania county have put the blame on pharmacy benefit managers—a new source of criticism for the industry. A report details $1.4 million in excess costs for […]

more info 02/05/2021View Related Articles
Bookmark and Share

Kathy High Reflects on Career and Future of Gene Therapy

Kathy High recently joined AskBio (Asklepios BioPharmaceutical, Inc.) as president after a long and successful career in gene therapy research. Jason Mast of Endpoints News discusses her impressive career and why taking a break made her more successful. Kathy High also reveals her thoughts on the […]

more info 02/05/2021View Related Articles
Bookmark and Share

Survey Results Will Be Announced in February

There’s not always a “right answer” to a problem. A survey explored how participants might respond to a marketing colleague requesting to sit in at an important data-heavy meeting. The purpose is to give survey participants a moment to reflect on multiple avenues. Results to this poll are expected […]

more info 02/05/2021View Related Articles
Bookmark and Share

Germany Announces RWE Data Collection for Novartis Zolgensma Gene Therapy

Germany’s Federal Joint Committee (GBA, Gemeinsamer Bundesausschuss) has announced a new registry study related to spinal muscular atrophy (SMA) drugs. Zolgensma (onasemnogene abeparvovec) gene therapy from Novartis will be compared to Spinraza (nusinersen) from Biogen. Nearly 500 children with SMA […]

more info 02/05/2021View Related Articles
Bookmark and Share

Cytel’s Advanced Design Framework to Improve Clinical Trials

Cytel has released its Advanced Design Framework as a method to minimize failed clinical trials. Ideally, biostatisticians are involved in clinical trial planning from the very beginning. This isn’t always possible, nor is it possible to account for every single variable. Cytel’s new technology […]

more info 02/04/2021View Related Articles
Bookmark and Share

2021 Medication Access Report Details Obstacles

The newly released 2021 Medication Access Report is now available. It details the challenges that people might face in accessing medication. In addition to patient testimony, the report includes data on medication access, as well as possible solutions. “The different paths to medication vary […]

more info 02/04/2021View Related Articles
Bookmark and Share

Racial and Ethnic Disparities and Possible Solutions in Light of the COVID-19 Crisis

Many studies have been undertaken to better understand the effects of the COVID-19 pandemic. It has also been noted that there remain serious racial and ethnic disparities related to the disease, its complications, and access to vaccines and healthcare. A recent study using data from a national […]

more info 02/04/2021View Related Articles
Bookmark and Share

  • Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 121
  • Next Page

 

View All JobsPost a JobView Current NewsletterSubscribe to Newsletters
Conference of the Week:

Link of the Week:

Job of the Week:

Webinar of the Week:

White Papers

  • Patient- or Participant-Generated Registries
  • Multinational Registries: Challenges and Opportunities
  • Managing Missing Data in Patient Registries
  • Biorepositories
  • Increasing Focus on the Patient in Patient Registries
  • DIA DIRECT: Real-World Data to Inform COVID-19 Response: Collaborating in the COVID-19 Evidence Accelerator
  • Demonstrating the Value of Drugs for Rare Diseases – 8 Common Challenges and How to Address Them Before They Arise
  • How to Put AI + Predictive Analytics To Work
  • Insurance Design and Pharmaceutical Innovation
  • Global Biosimilars Pathways and Clinical Development Activity
  • Telemedicine adoption grew in most EU5 markets as COVID mitigation measures took hold
  • Mitigating COVID-19-related healthcare disruption
  • Marketing during COVID-19: A guide for pharma solution providers
  • State of Patient Centricity 2020: Advancing from Patient-first Intentions to True Co-creation
  • Alternative Policies for Pricing Novel Vaccines and Drug Therapies for COVID-19
  • Bayesian Methodologies for COVID-19 Drugs, Devices and Biologics
  • Excellence In Payer Engagement: Strategic Outputs From A Roundtable Discussion
  • Evidence Generation and Communication: A Guide to Getting Started in HEOR/Market Access Medical Writing
  • Preparing for ICER assessments: key recommendations for manufacturers
  • Optimizing Patient Recruitment: Download Whitepaper
  • How Healthcare Providers and Payers Drive Outcome-Based Analytics
  • New Primer and Ebook on Synthetic Control Arms
  • Get Drugs & Devices to Market Faster
       Drugs & Devices to Market Faster with 21 CFR Part 11 Compliance
  • COVID-19 is impacting HTA priorities and processes
  • Leveraging Simulation to Patch a Clinical Trial Broken by COVID-19
  • A Systematic Approach to Assessing Real-World Research Questions Supported by Digital Enablement
  • Version 4.1 of the AMCP Format: Introducing a Trio of Dossiers to Support a Product Throughout its Lifecycle
  • Patient Preference Studies in HTA Decision Making: A NICE to Have?
  • Trends in Medical Device Purchasing, Evaluation of Value, and Advice for Manufacturers
  • Integrated Scientific Advice during the COVID-19 Pandemic

Syndicated Reports

  • Paying for Digital Health: Payer Insights
  • Benchmarking Pharma’s MSL Capabilities
  • Biosimilars: US Payer Perspectives
  • KAM Metrics: Driving Efficiency, Measuring Success
  • Biosimilars: E.U. Payer Perspectives
  • MSL Teams: Field Force Size and Structure
  • Market Access Impact: Type 2 Diabetes Mellitus (Injectables) (US) 2017
  • Market Access Impact: Type 2 Diabetes Mellitus (Orals) (US) 2017
  • Market Access Impact: Rheumatoid Arthritis (US) 2017
  • Pricing and Reimbursement in Oncology: Payer views
  • The ROI of Orphan Drugs: Ensuring Optimal Returns
  • New Syndicated Report – Orphan Drug Launch Strategies: Case Studies
  • New Syndicated Report: 2017 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers
  • Market Access Team Structure and Function: Industry Survey 2017
       New syndicated report available
  • Patient-Centered Risk Assessments – A Key Ingredient of Value-based Care
       New white paper by Sandra Hewett
  • The Future of Market Access in the U.S.
  • New Syndicated Report: The Future of Market Access in Europe
  • Syndicated Report: Biomarkers and Companion Diagnostics — Payer views
  • Syndicated Report: Why Pharma Needs to Get Serious about Data
  • Syndicated Report Available: How Payers Want to Work with Pharma
  • Syndicated report: The Future of Biosimilars in Europe
  • Syndicated report: World Preview 2017, Outlook to 2022
  • How Can MSL Performance be Measured Effectively?
  • Medical Writing: The Backbone of Clinical Development
  • The Future of Medical Affairs
  • Value-Based Healthcare: Making it Happen
  • Pricing and Market Access – Facts Versus Fiction
  • Is Your Market Access Team Making the Most of Real World Data Yet?
  • How Will Pricing Wars Shape the RA Landscape?
  • Benchmarking Biologic Innovator Value-Added-Services
HealthEconomics.Com

HealthEconomics.Com

  • Become a Better Writer!
  • HealthEconomics.Com Recognized as Top Influencer at ISPOR International Meeting in Washington DC
  • Will ICER Framework Destroy Progress Against Multiple Myeloma?
  • Celgene Unleashes the Power of Data into Clinical Trial Design
  • How Well is Harvoni Working in the Real World?
  • New CVS and Express Scripts Value Based Plans for Oncology
  • Oversized Cancer Drug Vials Waste $3B Each Year
  • Can More Data Make Providers’ Jobs Easier?
  • News
  • Conferences
  • Reports
  • Jobs
  • Consulting
  • Newsletters
  • White Papers

More Links

  • Take This Survey for a Chance to Win $200!
  • Jobs
  • Education
  • Graduate Schools
  • Webinar Services

Support & Contact

  • ICER Releases Two Draft Reports on Obeticholic Acid
  • What do Patient Advocates Think of New ICER Report?
  • Could a New ICER Report Put Patients at Risk?
  • Contact Us

About

  • International Myeloma Foundation Responds to ICER Report
  • About Us
  • Advertise
  • Webinar Services
  • HE Institute
  • Testimonials
  • Privacy Policy

Stay Connected

  • facebook
  • twitter
  • linkedin
  • pinterest
  • google-plus
  • youtube
  • rss

HealthEconomics.Com is the world’s most comprehensive and credible CONNECTED COMMUNITYTM that serves as the global link to the health economics & outcomes research (HEOR) and pharma market access stakeholder communities.

HEALTHECONOMICS HZ SMALL V2

HE Institute

Strategy, Training, Education, and Communications in HEOR & Market Access.

Innovation Webinar

Big ideas accelerating change in HEOR, RWE and Health Technology. Learn more!

tHEORetically Speaking Blog

Insights and observations for HEOR, market access, pricing, reimbursement, and health policy.

HE Jobs Portal

Your Premier Employment Source for HEOR, Market Access, and Real World Evidence

HE Webinars

Online educational and informational seminars for HEOR, market access, pricing, and reimbursement.
  • Doctor Evidence Launches GROWTH Replicator Program
  • Is PCORI Underfunding CER?
  • HealthEconomics.Com
  • About HealthEconomics.Com
  • Advertising Inquiries
  • Careers
  • Contact HealthEconomics.Com

HealthEconomics.Com is the world’s most comprehensive and credible CONNECTED COMMUNITYTM that serves as the global link to the health economics & outcomes research (HEOR) and pharma market access stakeholder communities, proving news, education, jobs, resources, policy updates, consulting, advertising, all available via website, newsletters, and social media.

© 2017 Health Economics. All rights reserved.

  • Will Improving Adherence Optimize Medication Use?
  • News
  • Jobs
    • HE Jobs Portal
    • View all Jobs
    • Post a Job
  • Value, Evidence and Access Marketplace
    • Visite the Marketplace
    • On-demand Webinar
  • Industry Events
    • HealthEconomics.Com Webinars
    • View Conferences
    • View Webinars
  • Newsletters
    • Subscribe
    • View All
  • Blog
  • Resources
    • Value Communication
    • Free Marketing Consultation!
    • The Future of Print Medical Journals: How to Stay Relevant
    • Be a Better Writer
    • White Papers
    • Education Resources
    • Syndicated Reports
    • Books
    • Databases
    • Blogs
      • HE-Artists
      • Podcasts
  • HE Institute